Skip to main content

In the pursuit to cure* chronic hepatitis C virus (HCV) genotype 1 infection…Healthcare Professional Resources

Register for OLYSIO<sup>®</sup> Updates

Register here to receive informative e-mails bringing the latest news regarding OLYSIO® and in the category of hepatitis C

The information you provide will only be used by Janssen Therapeutics, Division of Janssen Products, LP, our affiliates, and our service providers, to send you OLYSIO® and related disease state information. You may unsubscribe from receiving these communications by following the instructions that are included within the messages. Our Privacy Policy governs the use of the information you provide.

By providing the information and selecting the “Submit” button below, you indicate that you read, understand, and agree to these terms.”

*Required fields.

Registrant Personal Information

Registrant Professional Information